Sched.com Conference Mobile Apps
FierceBiotech 2nd Drug Development Forum
has ended
Create Your Own Event
FierceBiotech 2nd Drug Development Forum
Schedule
Simple
Expanded
Grid
By Venue
Speakers
Search
or browse by date + venue
Clinical Research Outsourcing and Technology
Digital Technology and Real-World Evidence
Improving R&D Outcomes
Networking
Plenary Sessions Day 1
Registration
Strategic Deal Making
Workshop Day
Popular
menu
Menu
Schedule
Speakers
Search
Girish Aakalu
IPSEN
Vice President and Head, Global Scientific Affairs and Scientific...
Michael Aberman
QUENTIS THERAPEUTICS
CEO
Irene Abrams
BOSTON CHILDREN’S HOSPITAL
Senior Director, Technology & Innovation Development Office
AA
Amirah Al-Idrus
FIERCEMARKETS
Editor
Chris Allen
SHIRE
Vice President, Head Counsel, US Litigation and Investigations
Richard Anders
MASS MEDICAL ANGELS
Founder
SA
Saurabh Awasthi
PWC
Director, Pharmaceutical and Life Sciences R&D Advisory
Mark Barrett
FRAZIER HEALTHCARE VENTURES
Entrepreneur in Residence
Roy Baynes
MERCK
Senior Vice President, Head of Clinical Development, Chief Medical...
Lewis Bender
INTENSITY THERAPEUTICS
CEO
Gad Berdugo
EPIVAX ONCOLOGY
CEO
Carl Berke
PARTNERS HEALTHCARE VENTURES
Partner
Nessan Bermingham
INTELLIA THERAPEUTICS
CEO
David Berry
FLAGSHIP PIONEERING
General Partner
Kevin Bitterman
ATLAS VENTURES
Partner
Natalia Borinshteyn
ABBVIE
former Vice President, Medical Affairs, HCV Launch Team
Katrine Bosley
EDITAS MEDICINE
CEO
Richard Brand
BEYONDSPRING PHARMACEUTICALS
CFO
SB
Stephen Brannan
KARUNA PHARMACEUTICALS
CMO
Richard Brudnick
BIOVERATIV
Executive Vice President, Business Development,
David Brush
JOHNSON & JOHNSON - BOSTON INNOVATION CENTER
Senior Director Transactions
John Burke
APPLIED BIOMATH
CEO
Christine Carberry
KERYX BIOPHARMACEUTICALS
COO
Jim Carroll
ICON
Vice President, Real-World Evidence, Commercialization and Outcomes
Martha Carter
ALBIREO PHARMA
Chief Regulatory Officer
Gail Cawkwell
PURDUE PHARMA LP
former CMO
Jesse Cedarbaum
BIOGEN
VP Clinical Development
Jeremy Chadwick
SHIRE
Group Vice President Clinical Development Operations
Vivien Chan
EUREKA THERAPEUTICS
Vice President, Portfolio Management
MC
Mark Chang
BOSTON UNIVERSITY
Adjunct Professor, Biostatistics
Josh Cohen
AMYLYX PHARMACEUTICALS CORP.
CEO and Founder
Dr. Laurence Cooper
ZIOPHARM ONCOLOGY INC.
CEO
Mark Cooper
FABER DAEUFER & ITRATO PC
Of Counsel
Mark Day
BIOASIS
CEO
Kelley Dealhoy
DELOITTE LLP
Senior Advisor, Life Sciences M&A
Susan Dettmar
DELOITTE CONSULTING LLP
Principal
SD
Shannon Devens
SURFACE ONCOLOGY
Executive Director, Clinical Operations
Heather DiBenedetto
MODERNA THERAPEUTICS
Vice President, Head of Therapeutic Operations,
Steve Dickman
CBT ADVISORS
CEO
John Dougherty
HAUG PARTNERS LLP
Partner
Deborah Dunsire
XTUIT PHARMACEUTICALS
CEO
Neal Farber
NEUROHEALING PHARMACEUTICALS
CEO
Maria Fardis
IOVANCE BIOTHERAPEUTICS
CEO
Maurizio Fava
MGH RESEARCH INSTITUTE
Director, Division of Clinical Research
Dennis Ford
LIFE SCIENCE NATION
CEO
CF
Colin Foster
W2O GROUP
Managing Director
Brian Gallagher
SR ONE
Partner
Karen Gardner
SEQIRUS
Senior Director, Clinical Development Operations
Bruce Goldsmith
LYCERA
COO
Paola Grandi
ONCORUS
Senior Director, Immunology / Virology
Angus Grant
CELEGNE
Corporate Vice President, Business Development
Luba Greenwood
ROCHE DIAGNOSTICS
VP, Global Mergers, Acquisitions, & Business Development
Richard Gregory
IMMUNOGEN
CSO
Jessica Grossman
MEDICINES360
CEO
Ruchi Gupta
MEDIMMUNE
Scientist
BG
Brian Guzik
ADVANTAGENE
Senior Director
Kimberly Ha
FTI CONSULTING
Senior Director, Strategic Communications
Andrew Hack
EDITAS MEDICINE
CFO
Scott Harris
LYRIC PHARMACEUTICALS
CMO
Mary Lynne Hedley
TESARO
COO
Carly Helfand
FIERCEMARKETS
Senior Editor
PH
Paulina Hill
POLARIS PARTNERS
Principal
Dana Hilt
LYSOSOMAL THERAPEUTICS INC
CMO
John Hohneker
FORMA THERAPEUTICS
President, Research and Development
Dan Housman
CONVERGEHEALTH BY DELOITTE
CTO
Martin Huber
TESARO
CMO
Eva Jack
MERSANA THERAPEUTICS
Chief Business Officer
Kenneth Kaitin
TUFTS CENTER FOR THE STUDY OF DRUG DEVELOPMENT
Director
Edward Kaye
SAREPTA THERAPEUTICS
CEO
Jennifer King
INTELLIA THERAPEUTICS
Senior Vice President
Justin Klee
AMYLYX PHARMACEUTICALS
President
Isaac Kohane
HARVARD MEDICAL SCHOOL
Chair, Department of Biomedical Informatics
Wiliam Korinek
ASTROCYTE PHARMACEUTICALS, INC.
CEO
Elizabeth Lewis
TAKEDA
Chief Counsel, Head of Patient Advocacy
Manuel Litchman
MUSTANG BIO
CEO
Casey Logan
TRACON PHARMACEUTICALS
CBO
Timothy Lowinger
MERSANA THERAPEUTICS
CSO
David Loynd
ENDURX PHARMACEUTICALS, INC.
CEO
Tracy Mayne
PURDUE PHARMA
Head of Medical Affairs Strategic Research
Krista McKee
TAKEDA
Director, Oncology Therapeutic Area Unit Operations
Ramon Mohanlal
BEYONDSPRING PHARMACEUTICALS
CMO
Lenny Moise
EPIVAX
Director, Vaccine Research
Jodie Morrison
TOKAI PHARMACEUTICALS
CEO
Donald Morrissey
SRS ACQUIOM
Managing Director, Head of Life Sciences
Richard Murray
JOUNCE THERAPEUTICS
CEO
Shakti Narayan
JOHNSON & JOHNSON
Vice President, Head of Transactions
Michael Needle
AVEO ONCOLOGY
CMO
Dawn Niccum
INSEPTION GROUP
Director, Quality Assurance
Sara Nochur
ALNYLAM PHARMACEUTICALS
Senior Vice President, Regulatory Affairs
EP
Eric Palmer
FIERCEMARKETS
Editor
Amit Rakhit
OVID THERAPEUTICS
Chief Medical and Portfolio Management Officer
Chandra Ramanathan
BAYER
Vice President and Head, East Coast Innovation Center
Rosemary Reilly
WILMERHALE
Partner
Sadiye Rieder
MEDIMMUNE
Scientist
AR
Adam Rosenberg
RODIN THERAPEUTICS
CEO
Lindsay Rosenwald
FORTRESS BIOTECH
CEO
Rob Scott
ABBVIE
Chief Medical Officer, VP Head of Development
Shoshana Shendelman
APPLIED THERAPEUTICS
CEO
DS
David Sherris
GENADAM THERAPEUTICS, INC.
Chief Executive Officer
Neal Simon
AZEVAN PHARMACEUTICALS
CEO
Karl Simpson
LIFTSTREAM
CEO
Evan Smith
FTI CONSULTING
Managing Director
Tracy Staton
FIERCEBIOTECH
Editor in Chief
RS
Ricky Sun
BAIN CAPITAL LIFE SCIENCES FUND
Principal
Steven Targum
FUNCTIONAL NEUROMODULATION
CMO
Charles Theuer
TRACON PHARMACEUTICALS
CEO
DT
David Thompson
INC RESEARCH / INVENTIV HEALTH
Senior Vice President, Real World Evidence and Insights
Nikola Trbovic
PFIZER
Director, R&D Technology Strategy, Genome Sciences and Technologies,...
DT
Doug Treco
RA PHARMACEUTICALS
Co-Founder, President and Chief Executive Officer
Nancy Valente
GENENTECH, INC
VP, Global Product Development
MV
Maria Vilenchik
FELICITEX THERAPEUTICS
CEO and Founder
Bridget Wagner
BROAD INSTITUTE
Director of Pancreatic Cell Biology, Chemical Biology Program
Sue Washer
APPLIED GENETIC TECHNOLOGIES CORPORATION
President & CEO
Arlene Weintraub
FIERCEBIOTECH
Contributing Writer
Yaron Werber
OVID THERAPEUTICS
Chief Business Officer
Keith Wilcoxen
TESARO, INC.
Senior Director, Scientific R&D
JW
James Williams
BIOGEN
Senior Director, Epidemiology, Value Based Medicine
Leslie Williams
IMMUSANT
CEO
Rebecca Willumson
FIERCEMARKETS, A DIVISION OF QUESTEX LLC
Vice President, Life Sciences & Healthcare
Travis Wilson
GURNET POINT CAPITAL
Partner
Bryon Wornson
PFIZER INCORPORATED
Vice President, Global Health and Value
QY
Qin Ye
REAL WORLD EVIDENCE LEAD
Andrew Young
INTARCIA THERAPEUTICS
CSO
Steven Zelenkofske
UNIQURE
CMO